Statin therapy in the secondary prevention of cerebrovascular events: is it really beneficial in clinical practice?
Mascitelli
Luca
L
Pezzetta
Francesca
F
Goldstein
Mark R
MR
D002318:Cardiovascular Diseases / Q000401:mortality* / Q000517:prevention & control*; D015897:Comorbidity; D064420:Drug-Related Side Effects and Adverse Reactions / Q000401:mortality* / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015994:Incidence; D018570:Risk Assessment; D012307:Risk Factors; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*; D016019:Survival Analysis; D015996:Survival Rate
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors